1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Aardvark Therapeutics, Inc. Common Stock

Aardvark Therapeutics, Inc. Common Stock

AARD
Aardvark Therapeutics, Inc. Common StockUS flagNASDAQ Global Select
6.08
USD
+0.55
- -
133.06MMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
11
7
23
63
+ Selling, General & Admin
3
2
5
14
+ Research & Development
7
4
17
49
+ Other Operating Expense
1
- -
- -
- -
Operating Income (Loss)
-11
-7
-23
-63
- Non-Operating (Income) Loss
3
1
-2
-5
+ Interest Expense, Net
- -
-1
-2
-5
+ Interest Expense
- -
- -
- -
- -
- Interest Income
- -
1
2
5
+ Other Non-Op (Income) Loss
3
2
- -
- -
Pretax Income
-14
-7
-21
-58
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-14
-7
-21
-58
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-14
-7
-21
-58
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-14
-7
-21
-58
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-14
-7
-21
-58
EBIT
-11
-7
-23
-63
EBITDA
-11
-7
-23
-63
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
-11
-7
-23
-63
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
10
13
21
20
Basic EPS, GAAP
-1.39
-0.56
-0.96
-2.93
Basic EPS from Cont Ops
-1.39
-0.56
-0.96
-2.93
Diluted Weighted Avg Shares
10
13
21
20
Diluted EPS, GAAP
-1.39
-0.56
-0.96
-2.93
Diluted EPS from Cont Ops
-1.39
-0.56
-0.96
-2.93

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
16
10
74
112
+ Cash, Cash Equivalents & STI
16
10
74
110
+ Cash & Cash Equivalents
16
10
62
47
+ ST Investments
1
- -
12
63
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
2
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
3
5
+ Property, Plant & Equip, Net
- -
- -
1
- -
+ Property, Plant & Equip
- -
- -
1
- -
- Accumulated Depreciation
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
- -
3
5
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
3
5
Total Assets
17
11
78
117
+ Payables & Accruals
- -
1
4
7
+ Accounts Payable
- -
1
2
2
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
1
5
+ ST Debt
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
1
3
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
1
3
Total Current Liabilities
1
1
5
11
+ LT Debt
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
+ Other LT Liabilities
44
44
127
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
44
44
127
- -
Total Noncurrent Liabilities
44
44
127
- -
Total Liabilities
45
45
132
11
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
3
3
4
222
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
3
3
4
222
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-31
-38
-58
-116
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-28
-35
-55
107
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-28
-35
-55
107
Total Liabilities & Equity
17
11
78
117
Shares Outstanding
21
21
22
22
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
- -
1
- -
Net Debt
-16
-10
-62
-47
Net Debt to Equity
55.72
27.97
112.81
-44.12
Tangible Common Equity Ratio
-166.63
-330.32
-70.5
91
Current Ratio
27.72
7.5
15.05
10.61
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-14
-7
-21
-58
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
4
1
1
3
+ Stock-Based Compensation
- -
- -
- -
4
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
4
1
- -
-1
+ Chg in Non-Cash Work Cap
-1
- -
2
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
- -
-6
+ Inc (Dec) in Accts Payable
-1
1
2
7
+ Inc (Dec) in Other
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-11
-6
-18
-54
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
91
+ Increase in Capital Stock
- -
- -
- -
91
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-12
-50
+ Dec in LT Investment
- -
- -
- -
80
+ Inc in LT Investment
- -
- -
-12
-130
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
-1
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
-1
- -
-12
-50
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
82
-2
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
- -
- -
82
89
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
-11
-6
52
-15
EBITDA
-11
-7
-23
-63
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
-11
-6
-18
-54
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-6
-18
-54
Free Cash Flow per Basic Share
-1.08
-0.45
-0.85
-2.77
Price/Free Cash Flow
- -
- -
- -
-4.76
Cash Flow to Net Income
0.78
0.81
0.88
0.94
Capital Expenditures
- -
- -
- -
- -